Cite
HARVARD Citation
Kwak, E. et al. (2013). Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation. Cancer. 119 (16), pp. 3043-3051. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kwak, E. et al. (2013). Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation. Cancer. 119 (16), pp. 3043-3051. [Online].